Search

Your search keyword '"Nekam K."' showing total 269 results

Search Constraints

Start Over You searched for: Author "Nekam K." Remove constraint Author: "Nekam K."
269 results on '"Nekam K."'

Search Results

1. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

2. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

3. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

4. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

5. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

6. The ARIA-MeDALL hypothesis

7. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

8. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

9. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

10. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

11. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

12. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

13. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

14. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

15. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

16. Management of anaphylaxis due to COVID-19 vaccines in the elderly

17. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

18. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

19. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

20. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

22. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper

23. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

24. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen)

25. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

26. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

27. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

28. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

29. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

30. Allergy and Clinical Immunology Services in Europe

31. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)

33. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

34. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

35. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

36. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

38. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

39. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

40. Controversial aspects of adverse reactions to food

41. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

42. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

43. Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries

44. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

46. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

47. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

48. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

49. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (vol 6, 29, 2016)

50. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

Catalog

Books, media, physical & digital resources